Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Oncology
Description:
Welcome to today’s episode, where we explore immunotherapy—the innovative approach that’s transforming cancer treatment. Unlike traditional therapies such as chemotherapy and radiation, immunotherapy harnesses the power of your own immune system to identify and attack cancer cells. Treatments like checkpoint inhibitors and CAR T-cell therapy are showing promising results, offering new hope for patients with advanced or hard-to-treat cancers. While not every patient responds the same way, ongoing research is refining these therapies to improve effectiveness and reduce side effects. Immunotherapy marks a significant shift, paving the way for more personalised and targeted cancer care. Stay tuned as we continue to follow this exciting development in oncology.
See More Webinars @ Hidoc Webinars
1.
According to JAMA, statin use may increase cancer-related survival in breast cancer patients.
2.
Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method
3.
Many patients learn they could have cancer in the emergency department
4.
For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.
5.
Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A
1.
Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management
2.
TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances
3.
Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications
4.
Stomach Cancer: Uncovering the Subtle Signs and Symptoms
5.
Gene Therapy for Hemophilia: A New Hope on the Horizon
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Comprehensive Update on Hematology
2.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
3.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge